Fundraising FoxAccure Therapeutics
5 known investors
Find your way into Accure Therapeutics
Sign up to see every warm intro you have to Accure Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Accure Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases. It operates in the biotech sector.
Founders & leadership
LN
Laurent NguyenChief Executive Officer, Board memberLaurent Nguyen is CEO of Accure Health, a biotech company developing CNS disease treatments. He brings experience across pharmaceutical development, commercialization, and business development, including prior roles in pharma marketing, sales, acquisitions, and medical practice.
PV
Pablo VillosladaCSOPablo Villoslada is a neurologist with over 20 years of experience in translational medicine across academia, biotech, medical devices, and pharmaceutical settings, with expertise spanning drug development (small molecules and cell therapy), clinical trial design and execution through Phase III, regulatory submissions, medical devices including neurostimulation, and digital health applications.
Investors · 5
Aliath Bioventures✓ confirmed by Accure TherapeuticsBarcelona
How we know: the company's own site · Not right? Tell us
Asabys Partnerslisted by Asabys PartnersBarcelona
How we know: Asabys Partners's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Alta Life SciencesreportedBarcelona
How we know: a partner's Signal profile · Not right? Tell us
Related companies · 5
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Acurx PharmaceuticalsAcurx Pharmaceuticals is a clinical-stage biopharmaceutical company developing a new class of antibiotics targeting bacterial infections classified as priority pathogens by the WHO, CDC, and FDA. It is a publicly held company focused on antibiotic drug development.
Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies working in the same space as Accure Therapeutics.
Frequently asked questions
- What does Accure Therapeutics do?
- Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases. It operates in the biotech sector.
- Who are Accure Therapeutics's investors?
- Accure Therapeutics's investors include Aliath Bioventures, Asabys Partners, Kinled Holding, Lifelink, Alta Life Sciences.